Chemoinformaics analysis of (-)-ALPHA-HYDROXYCITRIC-ACID
| Molecular Weight | 208.122 | nRot | 6 |
| Heavy Atom Molecular Weight | 200.058 | nRig | 3 |
| Exact Molecular Weight | 208.022 | nRing | 0 |
| Solubility: LogS | -0.101 | nHRing | 0 |
| Solubility: LogP | -0.967 | No. of Aliphatic Rings | 0 |
| Acid Count | 3 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 21.7703 |
| nHD | 4 | BPOL | 10.6297 |
| QED | 0.33 |
| Synth | 2.984 |
| Natural Product Likeliness | 1.146 |
| NR-PPAR-gamma | 0.414 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.019 |
| HIA | 0.764 |
| CACO-2 | -6.049 |
| MDCK | 0.0028169 |
| BBB | 0.083 |
| PPB | 0.118631 |
| VDSS | 0.305 |
| FU | 0.741877 |
| CYP1A2-inh | 0.005 |
| CYP1A2-sub | 0.029 |
| CYP2c19-inh | 0.024 |
| CYP2c19-sub | 0.034 |
| CYP2c9-inh | 0.018 |
| CYP2c9-sub | 0.26 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.083 |
| CYP3a4-inh | 0.025 |
| CYP3a4-sub | 0.002 |
| CL | 1.371 |
| T12 | 0.78 |
| hERG | 0.001 |
| Ames | 0.969 |
| ROA | 0.003 |
| SkinSen | 0.433 |
| Carcinogencity | 0.057 |
| EI | 0.972 |
| Respiratory | 0.158 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.929935 |